Memantine and recognition memory: Possible facilitation of its behavioral effects by the nitric oxide (NO) donor molsidomine

European Journal of Pharmacology

Volumn 571, Issue 2-3, 2007, Pages 174-179

  Pitsikas, Nikolaos ^a   Sakellaridis, Nikolaos ^a  

^a UNIVERSITY OF THESSALY   (Greece)

Author keywords

(Rat); Memantine; Molsidomine; Nitric oxide; NMDA; Recognition memory

Indexed keywords

MEMANTINE; MOLSIDOMINE; NITRIC OXIDE;

AMNESIA; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; MALE; MEMORY; NONHUMAN; PRIORITY JOURNAL; RAT; RECOGNITION;

ANIMALS; BEHAVIOR, ANIMAL; DISCRIMINATION LEARNING; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EXCITATORY AMINO ACID ANTAGONISTS; EXPLORATORY BEHAVIOR; EXTINCTION, PSYCHOLOGICAL; MALE; MEMANTINE; MOLSIDOMINE; MOTOR ACTIVITY; NITRIC OXIDE DONORS; NOOTROPIC AGENTS; RATS; RATS, WISTAR; RECOGNITION (PSYCHOLOGY); TIME FACTORS;

EID: 34548484099     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.06.019     Document Type: Article

References (46)

1. Abe H., and Iwasaki T. NMDA and muscarinic blockade in the perirhinal cortex impairs object discrimination in rats. NeuroReport 12 (2001) 3375-3379
2. Abe H., Ishida Y., and Iwasaki T. Perirhinal N-methyl-d-aspartate and muscarinic systems participate in object recognition in rats. Neurosci. Lett. 356 (2004) 191-194
3. Arancio O., Kieber M., Lee C.J., Lev-Ram V., Tsien R.Y., Kandel E.R., and Hawkins R.D. Nitric oxide acts directly in the presynaptic neuron to produce long-term potentiation in cultured hippocampal neurons. Cell 87 (1996) 1025-1035
4. Barnes C.A., Danysz W., and Parsons C.G. Effects of the uncompetitive NMDA receptor antagonist memantine on hippocampal long-term potentiation, short-term exploratory modulation and spatial memory in awake freely moving rats. Eur. J. Neurosci. 8 (1996) 565-571
5. Bartolini L., Casamenti F., and Pepeu G. Aniracetam restores object recognition impaired by age, scopolamine and nucleus basalis lesions. Pharmacol. Biochem. Behav. 53 (1996) 277-283
6. Bliss T.V., and Collingridge G.L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361 (1993) 31-39
7. Boger R.H., Bode-Boger S.M., Gerecke U., and Frolich J.C. Long-term administration of l-arginine, l-NAME and the exogenous NO donor molsidomine modulates urinary nitrate and cGMP excretion in rats. Cardiovasc. Res. 28 (1994) 494-499
8. Brenman J.E., and Bredt D.S. Synaptic signalling by nitric oxide. Curr. Opin. Neurobiol. 7 (1997) 374-378
9. Cavoy A., and Delacour J. Spatial but not object recognition is impaired by aging in rats. Physiol. Behav. 53 (1993) 527-530
10. Chen H.S., and Lipton S.A. The chemical biology of clinically tolerated NMDA receptor antagonists. J. Neurochem. 97 (2006) 1611-1626
11. Choi Y.B., Tenneti L., Le D.A., Ortiz J., Bai G., Chen H.S., and Lipton S.A. Molecular basis of the NMDA receptor-coupled ion channel modulation by S-nitrosylation. Nat. Neurosci. 3 (2000) 15-21
12. Collingridge G.L., and Singer W. Excitatory amino acids receptors and synaptic plasticity. Trends Pharmacol. Sci. 11 (1990) 290-296
13. De Lima M.N.M., Laranja D.C., Bromberg E., Roesler R., and Schroder N. Pre- or post-training administration of the NMDA receptor blocker MK-801 impairs object recognition memory in rats. Behav. Brain Res. 156 (2005) 139-143
14. Ennaceur A., and Delacour J. A new one-trial test for neurobiological studies of memory in rats 1: behavioral data. Behav. Brain Res. 31 (1988) 47-59
15. Feelisch M., Ostrowski J., and Noack E. On the mechanism of NO release from sydnonimines. J. Cardiovasc. Pharmacol. 14 (1989) S13-S22
16. Fin C., Cunha C.A., Bromberg E., Schmitz P.K., Bianchin M., Medina J.H., and Izquierdo L. Experiments suggesting a role for nitric oxide in the hippocampus in memory processes. Neurobiol. Learn. Mem. 63 (1995) 113-115
17. Flood J.F., Baker M.L., and Davis J.L. Modulation of memory processing by glutamic acid receptor agonists and antagonists. Brain Res. 521 (1990) 197-202
18. Garthwaite J. Glutamate nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci. 14 (1991) 60-67
19. Kim W.K., Choi Y.B., Rayudu P.V., Das P., Asaad W., Amelle D.R., Stamler J.S., and Lipton S.A. Attenuation of NMDA receptor activity and neurotoxicity by nitroxyl anion, NO-. Neuron 24 (1999) 461-469
20. Lupp A., Kerst S., and Karge E. Evaluation of possible pro- or antioxidative properties and of the interaction capacity with the microsomal cytochrome P450 system on different NMDA-receptor ligands and of taurine in vitro. Exp. Toxicol. Pathol. 54 (2003) 441-448
21. Maccario M., Oleandri S.E., Procopio M., Grottoli S., Avogadri E., and Camanni F. Comparisons among the effects of arginine, a nitric oxide precursor, isosorbide dinitrate and molsidomine, two nitric oxide donors on hormonal secretions and blood pressure in man. J. Endocrinol. Investig. 20 (1997) 488-492
22. Marvanova M., Lakso M., Pirhonen J., Nawa H., Wong G., and Castren E. The neuroprotective agent memantine induces brain-derived neurotrophic factor and trkB receptor expression in rat brain. Mol. Cell. Neurosci. 18 (2001) 247-258
23. Mayhan W.G. Nitric oxide donor-induced increase in permeability of blood-brain barrier. Brain Res. 866 (2000) 101-108
24. Meyer C.R., Spangler E.L., Patel N., London E.D., and Ingram D.K. Impaired learning in rats in a 14-unit T-maze by 7-nitroindazole, a neuronal nitric oxide synthase inhibitor, is attenuated by the nitric oxide donor, molsidomine. Eur. J. Pharmacol. 341 (1998) 17-22
25. Miguel-Hidalgo J.J., Alvarez X.A., Cacabelos R., and Quack G. Neuroprotection by memantine against neurodegeneration induced by beta-amyloid (1-40). Brain Res. 958 (2002) 210-221
26. Parsons C.G., Danysz W., and Quack G. Memantine is a clinically well tolerated N-methyl-d-aspartate (NMDA) receptor antagonist - a review of preclinical data. Neuropharmacology 38 (1999) 735-767
27. Pitkanen M., Sirvio J., MacDonald E., Niemi S., Ekonsalo T., and Riekkinen P. The effects of d-cycloserine and MK-801 on the performance of rats in two spatial learning and memory tasks. Eur. Neuropsychopharmacol. 5 (1995) 457-463
28. Pitsikas N., Rigamonti A.E., Cella S.G., Locatelli V., Sala M.E., and Muller E.E. Effects of molsidomine on scopolamine-induced amnesia and hypermotility in the rat. Eur. J. Pharmacol. 426 (2001) 193-200
29. Pitsikas N., Rigamonti A.E., Cella S.G., and Muller E.E. Effects of the nitric oxide donor molsidomine on different memory components as assessed in the object-recognition task in the rat. Psychopharmacology 162 (2002) 239-245
30. Pitsikas N., Rigamonti A.E., Bonomo S.M., Cella S.G., and Muller E.E. Molsidomine antagonizes l-NAME-induced acquisition deficits in a recognition memory task in the rat. Pharmacol. Res. 47 (2003) 311-315
31. Pitsikas N., Rigamonti A.E., Cella S.G., Sakellaridis N., and Muller E.E. The nitric oxide donor molsidomine antagonizes age-related memory deficits in the rat. Neurobiol. Aging 26 (2005) 259-264
32. Pitsikas N., Zisopoulou S., and Sakellaridis N. Nitric oxide donor molsidomine attenuates psychotomimetic effects of the NMDA receptor antagonist MK-801. J. Neurosci. Res. 84 (2006) 299-305
33. Prast H., and Philippu A. Nitric oxide as modulator of neuronal function. Prog. Neurobiol. 64 (2001) 51-68
34. Reisberg B., Doody R., Stoffer A., Scmitt F., Ferris S., and Mobius H.J. Memantine in moderate-to-severe Alzheimer's disease. N. Engl. J. Med. 348 (2003) 1333-1341
35. Sargolini F., Roullet P., Oliverio A., and Mele A. Effects of intra-accumbens focal administration of glutamate antagonists on object recognition memory in mice. Behav. Brain Res. 138 (2003) 153-163
36. Scarpini E., Scheltens P., and Feldman H. Treatment of Alzheimer's disease: current status and new perspectives. Lancet Neurol. 2 (2003) 539-547
37. Segieth J., Getting S.J., Biggs C.S., and Whitton P.S. Nitric oxide regulates excitatory amino acid release in a biphasic manner in freely moving rats. Neurosci. Lett. 200 (1995) 101-104
38. Segovia G., Porras A., and Mora F. Effects of a nitric oxide donor on glutamate and GABA release in striatum and hippocampus of the conscious rat. NeuroReport 5 (1994) 1937-1940
39. Spanagel R., Eilbacher B., and Wilke R. Memantine-induced dopamine release in the prefrontal cortex and striatum of the rat - a pharmacokinetic microdialysis study. Eur. J. Pharmacol. 262 (1994) 21-26
40. Steckler T., Drinkenburg W.H.I.M., Shagal A., and Aggleton J.P. Recognition memory in rats. -I Concepts and classification. Prog. Neurobiol. 54 (1998) 289-311
41. Wenk G.L., Zajaczkowski W., Danysz W., and Quack G. Neuroprotection of acetylcholinergic basal forebrain neurons by memantine and neurokinin B infusion of (+)-MK-801 and memantine: contrasting effects on radial maze learning in rats with entorhinal cortex lesions. Behav. Brain Res. 83 (1997) 129-133
42. Winters B.D., and Bussey T.J. Glutamate receptors in perirhinal cortex mediate encoding, retrieval and consolidation of object recognition memory. J. Neurosci. 25 (2005) 4243-4251
43. Yamada K., Noda Y., Hasegawa T., Komori Y., Nikai T., Sughihara H., and Nabeshima T. The role of nitric oxide in dizocilpine-induced impairment of spontaneous alternation behavior in mice. J. Pharmacol. Exp. Ther. 276 (1996) 460-466
44. Zaiaczkowski W., Quack G., and Danysz W. Infusion of (+)-MK-801 and memantine - contrasting effects on radial maze learning in rats with entorhinal cortex lesions. Eur. J. Pharmacol. 296 (1996) 239-246
45. Zaiaczkowski W., Frankiewicz T., Parsons C.G., and Danysz W. Uncompetitive NMDA receptor antagonists attenuate NMDA-induced impairment of passive avoidance learning and LTP. Neuropharmacology 36 (1997) 961-971
46. Zoladz P.R., Campbell A.M., Park C.R., Schaefer D., Danysz W., and Diamond D.M. Enhancement of long-term spatial memory in adult rats by the noncompetitive NMDA receptor antagonists memantine and neramexane. Pharmacol. Biochem. Behav. 85 (2006) 298-306